Mayo Clinic recruits for fasting protocol trial in GLP-1 users before endoscopy
The study tests whether extending pre-procedure fasting lowers gastric residual volume, the proxy for aspiration risk in patients on GLP-1 receptor agonists.
PR
By Priya Raman · Science Reporter
Oct 5 08:00 ETSource: ClinicalTrials.gov
The wire
- 01Mayo Clinic is recruiting for NCT07006142, a non-randomized study started August 1, 2025, measuring gastric residual volume at upper endoscopy under a modified fasting protocol in patients prescribed GLP-1 receptor agonists.
- 02Pre-procedure fasting guidance for GLP-1 patients remains contested between anesthesiology and gastroenterology groups, and endoscopy schedulers and prescribers still lack trial data to justify holding or extending fasts.
- 03The trial is listed as recruiting with no results posted; gastric residual volume is a surrogate for aspiration, not a measure of aspiration events themselves.
From the source
Read at clinicaltrials.govEffect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists
NCT07006142 · NA · RECRUITING · Sponsor: Mayo Clinic · Conditions: Upper Endoscopy, GLP1-R-related Disease.
Source URL https://clinicaltrials.gov/study/NCT07006142
